Cargando…
Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux
The protein kinase C (PKC) family of serine/threonine kinases are pleiotropic signaling regulators and are implicated in hematopoietic signaling and development. Only one isoform however, PKCϵ, has oncogenic properties in solid cancers where it is associated with poor outcomes. Here we show that PKC...
Autores principales: | Nicholson, Rachael, Menezes, Ana Catarina, Azevedo, Aleksandra, Leckenby, Adam, Davies, Sara, Seedhouse, Claire, Gilkes, Amanda, Knapper, Steve, Tonks, Alex, Darley, Richard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191576/ https://www.ncbi.nlm.nih.gov/pubmed/35707351 http://dx.doi.org/10.3389/fonc.2022.840046 |
Ejemplares similares
-
RUNX3 overexpression inhibits normal human erythroid development
por: Menezes, Ana Catarina, et al.
Publicado: (2022) -
Increased expression of RUNX3 inhibits normal human myeloid development
por: Menezes, Ana Catarina, et al.
Publicado: (2022) -
Use of an anti‐CD200‐blocking antibody improves immune responses to AML in vitro and in vivo
por: Rastogi, Namrata, et al.
Publicado: (2020) -
Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
por: Raut, Lalit S.
Publicado: (2015) -
Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.
por: Galettis, P., et al.
Publicado: (1994)